What are the considerations for using tirzepatide (a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist) in patients with pre-existing gastrointestinal conditions, such as gastroparesis, inflammatory bowel disease, or irritable bowel syndrome?
Taken together, these findings highlight the need to consider sex-specific hormonal profiles when designing and implementing VLEKT protocols, in order to enhance efficacy and support personalised obesity management strategies
The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice
Two Buttons on Stomach and Brainstem A quick mental model that helps: imagine the hiccup reflex as a doorbell with two buttons, one on the stomach and one in the brainstem
Clinical trials reveal that semaglutide not only enhances glycemic control but also significantly aids in weight reduction, an area where many of its peers struggle to show pronounced results